PITTSBURGH, Oct. 7 Findings published in this month's issue of Clinical Cancer Research and featured on the journal's cover, may bring researchers one-step closer to the development of tumor markers to detect colon cancer early, before it has had a chance to spread and when it is easier to cure, say researchers from the University of Pittsburgh Cancer Institute (UPCI). These tumor markers elevated levels of proteins or other substances in the blood, urine or tissue that indicate the presence of cancer also could help identify which patients with colon cancer are more likely to develop recurrent disease.
In the study, Robert Getzenberg, Ph.D., senior author and associate professor of urology, pathology and pharmacology at the University of Pittsburgh and co-director, Prostate and Urologic Cancer Program, UPCI and colleagues analyzed cancerous tissue resulting from colon cancer that had spread to the liver the most common site for colon cancer to recur and found three proteins present in the diseased liver tissue that were not present in normal liver tissue. The findings add to previous findings published earlier this year in the journal Cancer Research in which the same researchers identified four different proteins present in colon cancer tumor samples that were not found in normal colon tissue.
"Identifying a specific and sensitive tumor marker that would allow reliable early detection of colon cancer and predict the potential for the cancer to spread or recur would be of great benefit to patients," said Dr. Getzenberg. "Early diagnosis of recurrent colon cancer is critical to effective treatment of the disease, however, colon cancer metastases are very difficult to pick up early. Thirty-five to 40 percent of all patients with colon cancer have recurrent disease and the majority of these patients cannot be cured and will eventually die."
The researchers analyzed a subset of proteins in the cell nucleus called nuclear matrix proteins, Page: 1 2 3 Related biology news :1
Contact: Clare Collins
University of Pittsburgh Medical Center
. Indiana University, EPA to study airborne PCBs2
. University of Alberta researcher looks for clues to mysterious disease3
. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute4
. Washington University in St. Louis leads group studying aging process5
. Tufts University establishes $4 million dollar tissue engineering resource center6
. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University7
. As informatics grows, Indiana University helps set research agenda8
. University of Arizona licenses patent for natural fungicide9
. Washington University in St. Louis plays key role in sequencing moss genome10
. University of Pittsburgh receives $10 million grant for head and neck cancer11
. Clemson University spin-off uses corn to make plastics, provide cleaner air